Comisia European\u0103 a acordat o autoriza\u0163ie de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103 (AIC) pentru vaccinul \u00eempotriva COVID-19 creat de Moderna, acesta fiind al doilea vaccin \u00eempotriva COVID-19 autorizat \u00een UE. Autoriza\u0163ia a urmat o recomandare \u015ftiin\u0163ific\u0103 favorabil\u0103 bazat\u0103 pe o evaluare aprofundat\u0103 a siguran\u0163ei, eficacit\u0103\u0163ii \u015fi calit\u0103\u0163ii vaccinului de c\u0103tre Agen\u0163ia European\u0103 pentru Medicamente (EMA) \u015fi aprobat\u0103 de statele membre, arat\u0103 https:\/\/ec.europa.eu\/.<\/p>\n
Comisia European\u0103 a propus statelor membre ale UE s\u0103 achizi\u0163ioneze 200 de milioane de doze suplimentare de vaccin \u00eempotriva COVID-19 produs de BioNTech \u015fi Pfizer, cu op\u0163iunea de a achizi\u0163iona \u00eenc\u0103 100 de milioane de doze. Aceasta ar permite UE s\u0103 cumpere p\u00e2n\u0103 la 600 de milioane de doze din acest vaccin, care este utilizat deja \u00een \u00eentreaga UE. UE a achizi\u0163ionat un vast portofoliu de vaccinuri produse cu diferite tehnologii, asigur\u00e2nd p\u00e2n\u0103 la 2,3 miliarde de doze din cele mai promi\u0163\u0103toare vaccinuri poten\u0163iale, care ar permite UE nu numai s\u0103 acopere necesit\u0103\u0163ile \u00eentregii sale popula\u0163ii, ci \u015fi s\u0103 furnizeze vaccinuri \u0163\u0103rilor \u00eenvecinate.<\/p>\n
***<\/p>\n
Comisia European\u0103 a decis s\u0103 \u00eenregistreze o ini\u0163iativ\u0103 cet\u0103\u0163eneasc\u0103 european\u0103 (ICE) intitulat\u0103 „Ini\u0163iativa societ\u0103\u0163ii civile pentru interzicerea practicilor de supraveghere biometric\u0103 \u00een mas\u0103”. Organizatorii ICE \u00eendeamn\u0103 Comisia s\u0103 propun\u0103 un act juridic care s\u0103 pun\u0103 cap\u0103t \u00een mod permanent utiliz\u0103rilor nediferen\u0163iate \u015fi arbitrare ale datelor biometrice \u00een moduri care ar putea conduce la activit\u0103\u0163i de supraveghere \u00een mas\u0103 sau la interferen\u0163e nejustificate cu drepturile fundamentale.<\/p>\n
Ini\u0163iativa cet\u0103\u0163eneasc\u0103 european\u0103 a fost introdus\u0103 odat\u0103 cu Tratatul de la Lisabona, ca instrument prin care cet\u0103\u0163enii pot contribui la stabilirea agendei de lucru. A fost lansat\u0103 \u00een mod oficial \u00een aprilie 2012. Odat\u0103 \u00eenregistrat\u0103 oficial, o ini\u0163iativ\u0103 cet\u0103\u0163eneasc\u0103 european\u0103 d\u0103 posibilitatea unui num\u0103r de 1 milion de cet\u0103\u0163eni din cel pu\u0163in un sfert din statele membre ale UE s\u0103 invite Comisia European\u0103 s\u0103 propun\u0103 acte juridice \u00een domeniile \u00een care Comisia are competen\u0163a de a ac\u0163iona. De la \u00eenceputul ini\u0163iativei cet\u0103\u0163ene\u015fti europene, Comisia a \u00eenregistrat \u00een total 76 de ini\u0163iative cet\u0103\u0163ene\u015fti \u015fi a refuzat 26, care nu \u00eendeplineau condi\u0163iile de admisibilitate necesare, arat\u0103 https:\/\/ec.europa.eu\/.<\/p>\n
Sursa: AGERPRES<\/p>\n
<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Comisia European\u0103 a acordat o autoriza\u0163ie de introducere pe pia\u0163\u0103 condi\u0163ionat\u0103 (AIC) pentru vaccinul \u00eempotriva COVID-19 creat de Moderna, acesta fiind al doilea vaccin \u00eempotriva COVID-19 autorizat \u00een UE. Autoriza\u0163ia a urmat o recomandare \u015ftiin\u0163ific\u0103 favorabil\u0103 bazat\u0103 pe o evaluare aprofundat\u0103 a siguran\u0163ei, eficacit\u0103\u0163ii \u015fi calit\u0103\u0163ii vaccinului de c\u0103tre Agen\u0163ia European\u0103 pentru Medicamente (EMA) \u015fi … Continued<\/a><\/p>\n","protected":false},"author":4,"featured_media":11609,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[8],"tags":[],"_links":{"self":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/12124"}],"collection":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12124"}],"version-history":[{"count":1,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/12124\/revisions"}],"predecessor-version":[{"id":12125,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/12124\/revisions\/12125"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/media\/11609"}],"wp:attachment":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}